Inventor
Lawrence C. Fritz
Inventor
Rancho Santa Fe, CA, US
Overview
Patents· 16 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides17%
G01NInvestigating or analysing materials by determining their chemical or physical properties17%
A61KPreparations for medical, dental or toiletry purposes11%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations11%
A01NPreservation of bodies of humans or animals or plants or parts thereof9%
C12NMicroorganisms or enzymes7%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests7%
A01KAnimal husbandry6%
A61QSpecific use of cosmetics or similar toiletry preparations6%
Y02ATechnologies for adaptation to climate change4%
PatentTitleYear
7,465,718'Ansamycins having improved pharmacological and biological properties'20086,762,045'Membrane derived caspase-3, compositions comprising the same and methods of use therefor'20046,693,096'Treatment of inflammation-associated disorders using interleukin-1-converting enzyme (ICE)/CED-3 family inhibitors'20046,610,683'Treatment of infectious disease using interleukin-1-converting enzyme (ICE)/CED-3 family inhibitors'20036,531,467'Inhibition of inflammation using interleukin-1-converting enzyme (ICE)/CED-3 family inhibitors'20036,528,506'Inhibition of apoptosis using interleukin-1-converting enzyme (ICE)/CED-3 family inhibitors'20036,518,032'Rapid methods for identifying modifiers of cellular apoptosis activity'20036,391,575'Methods for detecting membrane derived caspase activity and modulators thereof'20026,270,980'Rapid methods for identifying modifiers of cellular apoptosis activity'20016,251,614'Rapid methods for identifying modifiers of cellular apoptosis activity'20016,200,969'Inhibition of apoptosis using interleukin-1.beta.-converting enzyme (ICE)/CED-3 family inhibitors'20016,018,024'Methods and compositions for monitoring cellular processing of beta-amyloid precursor protein'20005,721,130'Antibodies and fragments thereof which bind the carboxyl-terminus of an amino-terminal fragment of .beta.APP'19985,605,811'Methods and compositions for monitoring cellular processing of beta-amyloid precursor protein'19975,559,004'Methods for screening compounds to determine calcium leak channel inhibition activity'19965,441,870'Methods for monitoring cellular processing of .beta.-amyloid precursor protein'1995Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1995–1998Patents assigned to ATHENA NEUROSCIENCES INC (4)· patent assignee history
1995–1998Patents assigned to LILLY CO ELI (3)· patent assignee history
1995–2000Based in San Francisco, CA, US· patent location history
2000Patents assigned to ELAN PHARM INC (1)· patent assignee history
2001–2004Patents assigned to IDUN PHARMACEUTICALS INC (10)· patent assignee history
2001–2008Based in Rancho Santa Fe, CA, US· patent location history
2008Patents assigned to CONFORMA THERAPEUTICS CORP (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| IDUN PHARMACEUTICALS INC | 10 | 2001–2004 |
| ATHENA NEUROSCIENCES INC | 4 | 1995–1998 |
| LILLY CO ELI | 3 | 1995–1998 |
| CONFORMA THERAPEUTICS CORP | 1 | 2008 |
| ELAN PHARM INC | 1 | 2000 |
Locations
| Location | Patents | Span |
|---|---|---|
| Rancho Santa Fe, California, US | 11 | 2001–2008 |
| San Francisco, California, US | 5 | 1995–2000 |